A
$ Value
$0
Shares
1,000,000
Price
$0
Filed
Jun 25
Insider
Name
Marasco Dominic
Title
Pres, Endocrine Business Unit
CIK
0002053897
Roles
Officer
Transaction Details
Transaction Date
2025-06-23
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,000,000
Footnotes
Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. | The performance-based restricted stock unit will vest on March 15, 2028. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, will be determined by the achievement of a specified net sales target, with the potential payout ranging from 0% to 200%.
Filing Info
Marasco Dominic's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-06-23 | MNKD | A | $0 |
| 2025-05-14 | MNKD | A | $0 |
| 2025-05-14 | MNKD | A | $100K |
| 2025-05-14 | MNKD | A | $0 |
Other Insiders at MNKD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Castagna Michael
Chief Executive Officer
|
$259K | — | 2026-03-23 |
| HOOPER ANTHONY C | — | — | 2026-03-01 |
|
Thomson David
EVP Genl Counsel & Secretary
|
— | — | 2026-03-23 |
| Shannon James Samuel | — | — | 2026-03-01 |
|
Tross Stuart A
Chief People & Workpl Officer
|
— | — | 2026-03-23 |
| Binder Steven B. | — | — | 2026-02-26 |
|
Prentiss Christopher B
Chief Financial Officer
|
— | — | 2026-03-23 |
|
Singh Sanjay R
EVP Technical Operations
|
— | — | 2026-03-23 |
|
Ahuja Ajay
Chief Medical Officer
|
— | — | 2026-03-23 |